Meyka Pro banner
Anteris Technologies Global Corp.

Anteris Technologies Global Corp. (AVR) Stock Overview

Explore Anteris Technologies Global Corp.’s financial performance, market position, analyst ratings, and future outlook.

AVR●NASDAQ
HealthcareMedical - Devices
$6.18
$0.13(2.15%)
U.S. Market opens in 1h 32m

Anteris Technologies Global Corp. (AVR)

Meyka AI Score

Z

Key Financials

Market Cap601.8M
P/E Ratio-2.24
EPS (TTM)$-1.94
ROE-0.78%
Fundamental Analysis

AI Price Forecasts

1 Month$4.12
3 Months$9.09
1 Year Target$8.80

AVR Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Anteris Technologies Global Corp. (NASDAQ: AVR) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Anteris Technologies Global Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AVR on the NASDAQ shows an RSI of 27.58, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $8.80 for the NASDAQ listing.

Key metrics behind Anteris Technologies Global Corp.'s NASDAQ-traded stock include a P/E ratio of -2.24 and a market capitalization of 601.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of AVR on the NASDAQ.

Price Performance (NASDAQ: AVR)

1-Day Change
2.15%
5-Day Change
-2.37%
1-Month Change
-24.26%
3-Month Change
-26.86%
6-Month Change
1.81%
Year-to-Date (YTD) Change
23.85%
1-Year Change
4.22%
3-Year Change
10.36%
5-Year Change
10.36%
All-Time (Max) Change
10.36%

Contact Information

61 13 0055 0310
860 Blue Gentian Road, Suite 340, Eagan, MN, 55121

Company Facts

1,740 Employees
IPO DateDec 13, 2024
CountryUS
Actively Trading

Frequently Asked Questions